Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 132

    1.

    Nonhuman primate models for diabetic ocular neovascularization using AAV2-mediated overexpression of vascular endothelial growth factor.

    Lebherz C, Maguire AM, Auricchio A, Tang W, Aleman TS, Wei Z, Grant R, Cideciyan AV, Jacobson SG, Wilson JM, Bennett J.

    Diabetes. 2005 Apr;54(4):1141-9.PMID: 15793254 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Anti-vascular endothelial growth factor therapy for ocular neovascular disease.

    Andreoli CM, Miller JW.

    Curr Opin Ophthalmol. 2007 Nov;18(6):502-8. Review.PMID: 18163003 [PubMed - indexed for MEDLINE]Related articles

    3.

    Pathologic features of vascular endothelial growth factor-induced retinopathy in the nonhuman primate.

    Tolentino MJ, McLeod DS, Taomoto M, Otsuji T, Adamis AP, Lutty GA.

    Am J Ophthalmol. 2002 Mar;133(3):373-85.PMID: 11860975 [PubMed - indexed for MEDLINE]Related articles

    4.

    Enhanced recombinant adeno-associated virus-mediated vascular endothelial growth factor expression in the adult mouse retina: a potential model for diabetic retinopathy.

    Rakoczy PE, Brankov M, Fonceca A, Zaknich T, Rae BC, Lai CM.

    Diabetes. 2003 Mar;52(3):857-63.PMID: 12606531 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    [Aging and retinal vascular diseases]

    Takagi H.

    Nippon Ganka Gakkai Zasshi. 2007 Mar;111(3):207-30; discussion 231. Review. Japanese. PMID: 17402563 [PubMed - indexed for MEDLINE]Related articles

    6.

    Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives.

    Caldwell RB, Bartoli M, Behzadian MA, El-Remessy AE, Al-Shabrawey M, Platt DH, Caldwell RW.

    Diabetes Metab Res Rev. 2003 Nov-Dec;19(6):442-55. Review.PMID: 14648803 [PubMed - indexed for MEDLINE]Related articles

    7.

    Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress.

    Caldwell RB, Bartoli M, Behzadian MA, El-Remessy AE, Al-Shabrawey M, Platt DH, Liou GI, Caldwell RW.

    Curr Drug Targets. 2005 Jun;6(4):511-24. Review.PMID: 16026270 [PubMed - indexed for MEDLINE]Related articles

    8.

    Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy.

    Watanabe D, Suzuma K, Matsui S, Kurimoto M, Kiryu J, Kita M, Suzuma I, Ohashi H, Ojima T, Murakami T, Kobayashi T, Masuda S, Nagao M, Yoshimura N, Takagi H.

    N Engl J Med. 2005 Aug 25;353(8):782-92.PMID: 16120858 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Novel anti-VEGF chimeric molecules delivered by AAV vectors for inhibition of retinal neovascularization.

    Pechan P, Rubin H, Lukason M, Ardinger J, DuFresne E, Hauswirth WW, Wadsworth SC, Scaria A.

    Gene Ther. 2009 Jan;16(1):10-6. Epub 2008 Jul 17.PMID: 18633446 [PubMed - indexed for MEDLINE]Related articles

    10.

    Long-term evaluation of AAV-mediated sFlt-1 gene therapy for ocular neovascularization in mice and monkeys.

    Lai CM, Shen WY, Brankov M, Lai YK, Barnett NL, Lee SY, Yeo IY, Mathur R, Ho JE, Pineda P, Barathi A, Ang CL, Constable IJ, Rakoczy EP.

    Mol Ther. 2005 Oct;12(4):659-68.PMID: 16023893 [PubMed - indexed for MEDLINE]Related articles

    11.

    Gene therapy for ocular angiogenesis.

    Bainbridge JW, Mistry AR, Thrasher AJ, Ali RR.

    Clin Sci (Lond). 2003 Jun;104(6):561-75. Review.PMID: 12570869 [PubMed - indexed for MEDLINE]Related articles

    12.

    Leptin stimulates ischemia-induced retinal neovascularization: possible role of vascular endothelial growth factor expressed in retinal endothelial cells.

    Suganami E, Takagi H, Ohashi H, Suzuma K, Suzuma I, Oh H, Watanabe D, Ojima T, Suganami T, Fujio Y, Nakao K, Ogawa Y, Yoshimura N.

    Diabetes. 2004 Sep;53(9):2443-8.PMID: 15331557 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Helper-dependent adenovirus for the gene therapy of proliferative retinopathies: stable gene transfer, regulated gene expression and therapeutic efficacy.

    Lamartina S, Cimino M, Roscilli G, Dammassa E, Lazzaro D, Rota R, Ciliberto G, Toniatti C.

    J Gene Med. 2007 Oct;9(10):862-74.PMID: 17685494 [PubMed - indexed for MEDLINE]Related articles

    14.

    Marked inhibition of retinal neovascularization in rats following soluble-flt-1 gene transfer.

    Rota R, Riccioni T, Zaccarini M, Lamartina S, Gallo AD, Fusco A, Kovesdi I, Balestrazzi E, Abeni DC, Ali RR, Capogrossi MC.

    J Gene Med. 2004 Sep;6(9):992-1002.PMID: 15352072 [PubMed - indexed for MEDLINE]Related articles

    15.

    Overexpression of VEGF-A induces neovascularization and increased vascular leakage in rabbit eye after intravitreal adenoviral gene transfer.

    Kinnunen K, Korpisalo P, Rissanen TT, Heikura T, Viita H, Uusitalo H, Ylä-Herttuala S.

    Acta Physiol (Oxf). 2006 Aug;187(4):447-57.PMID: 16866776 [PubMed - indexed for MEDLINE]Related articles

    16.

    Intraocular route of AAV2 vector administration defines humoral immune response and therapeutic potential.

    Li Q, Miller R, Han PY, Pang J, Dinculescu A, Chiodo V, Hauswirth WW.

    Mol Vis. 2008 Sep 24;14:1760-9.PMID: 18836574 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.

    Stalmans I.

    Verh K Acad Geneeskd Belg. 2005;67(4):229-76. Review.PMID: 16334858 [PubMed - indexed for MEDLINE]Related articles

    18.

    Suppression of retinal neovascularization by shRNA targeting HIF-1alpha.

    Xia XB, Xiong SQ, Xu HZ, Jiang J, Li Y.

    Curr Eye Res. 2008 Oct;33(10):892-902.PMID: 18853324 [PubMed - indexed for MEDLINE]Related articles

    19.

    VEGF165b, an endogenous C-terminal splice variant of VEGF, inhibits retinal neovascularization in mice.

    Konopatskaya O, Churchill AJ, Harper SJ, Bates DO, Gardiner TA.

    Mol Vis. 2006 May 26;12:626-32.PMID: 16735996 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    A reproducible and quantifiable model of choroidal neovascularization induced by VEGF A165 after subretinal adenoviral gene transfer in the rabbit.

    Julien S, Kreppel F, Beck S, Heiduschka P, Brito V, Schnichels S, Kochanek S, Schraermeyer U.

    Mol Vis. 2008 Jul 30;14:1358-72.PMID: 18682809 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data